NCT05407740View on ClinicalTrials.gov

"Association of Proteinuria and Progression of Kidney Dysfunction in Sickle Cell DiseaseDisease"

CompletedOBSERVATIONAL
Enrollment

355

Participants

Timeline

Start Date

March 1, 2021

Primary Completion Date

March 1, 2021

Study Completion Date

December 1, 2021

Conditions
Change in Albumin to Creatinine Ratio and Glomerular Filtration RateProgression of Kidney Failure and or All-cause Mortality
Interventions
OTHER

no intervention study

no intervention study

Trial Locations (1)

94000

Henri Mondor Hospital, Créteil

Sponsors

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

Soutien aux Actions contre les Maladies du Globule Rouge

OTHER

NCT05407740 - "Association of Proteinuria and Progression of Kidney Dysfunction in Sickle Cell DiseaseDisease" | Biotech Hunter | Biotech Hunter